US FDA and EMA accepted filings based on the data from OCARINA II, with EU approval anticipated mid-2024 and U.S. approval anticipated September 2024
The exclusive agreement between AAHI and Croda includes a collaborative effort in research and development
_256_384.jpg)
This facility manufactures APIs & formulations of oncology and non-oncology products.
Wacker Biotech is a CDMO for the GMP-compliant production of active ingredients for the pharmaceutical industry
Highly effective preservation solutions ensuring the safety and protection of personal care products
The company had earlier announced about the approval received from the MHRA for Liraglutide
Liraglutide is a drug-device combination formulation used in the treatment of Type 2 Diabetes Mellitus
Letermovir tablets, 240 mg and 480 mg had annual sales of USD 289.5 mn in the United States (IQVIA MAT Jan-24)
The drug will be manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ II, India
More than 10,000 scientific publications containing EUDRAGIT
Subscribe To Our Newsletter & Stay Updated
